Home > PJ (current issue) > The Society | Search

The Pharmaceutical Journal
Vol 277 No 7425 p558
4 November 2006


Society summary

 Law and Ethics Bulletin

An occasional feature, prepared in the Royal Pharmaceutical Society’s Professional Standards Directorate, to highlight problems and inquiries currently being handled

Law and Ethics Bulletin, 2001 to present


Licence requirements for the prescribing of cocaine, diamorphine and dipipanone for addiction

Pharmacists are reminded that doctors may only write prescriptions and authorise the supply of certain Schedule 2 Controlled Drugs for the treatment of addiction if they are licensed to do so by the Home Office acting for the Secretary of State.

The only Controlled Drugs to which this requirement applies are cocaine, diamorphine, dipipanone and their salts. A licence is required when these drugs are prescribed for an addicted person for the purpose of treating their addiction.

A licence would not be required when a doctor prescribes these items for the purpose of treating organic disease or injury.

Upon receipt of a prescription for these items for use in the treatment of addiction, pharmacists are advised to make the appropriate checks to confirm whether the doctor has the necessary licence to enable him to prescribe in these circumstances. If it is not clear whether the doctor is prescribing the item for treating organic disease or injury or for addiction, the pharmacist is advised to contact the prescriber for confirmation.

The Drug Licensing Unit of the Home Office holds details of the licences held and can be contacted via the Home Office switchboard on 0870 000 1585.

Back to Top


©The Pharmaceutical Journal